Serum Amyloid A test kit 18-02 series

oncologyinfectiongynecology

Serum amyloid A (SAA) is a precursor substance of amyloid deposition, which is secreted by the liver. It is an acute phase response protein, belonging to a heterogeneous protein in the apolipoprotein family. In the acute phase of inflammation or infection, it rises rapidly within 4-6 hours, and decreases rapidly during the recovery period of the disease. Product description Serum amyloid A (SAA) is a precursor substance of amyloid deposition, which is secreted by the liver. It is an acute phase response protein, belonging to a heterogeneous protein in the apolipoprotein family. In the acute phase of inflammation or infection, it rises rapidly within 4-6 hours, and decreases rapidly during the recovery period of the disease. Apply to：Emergency department, respiratory department, pediatrics, ICU, obstetrics and gynecology, surgery, oncology, hematology... detection principle and method This reagent uses immunofluorescence to detect the concentration of SAA in whole blood, serum or plasma. Clinical application For certain diseases, such as viral infection, transplant rejection, coronary heart disease, etc., SAA is more sensitive than CRP. As a new detection indicator, SAA can diagnose and monitor clinically related diseases. Provide valuable information on disease development and guide clinical treatment. Features It is determined by time-resolved immunofluorescence chromatography with high sensitivity and strong specificity. The reaction time is short and the batch processing speed is fast. Instrument interpretation, full quantitative detection, accurate and reliable. The operation is simple, and the two-step detection can be completed.